Orchid Pharma Ltd NSE:ORCHPHARMA:
ORCHID PHARMA - SIGNS LICENSING AGREEMENT WITH PHARMASYNTEZ TO COMMERCIALIZE EXBLIFEP IN RUSSIA
ORCHID PHARMA - PARTNERSHIP REPRESENTS POTENTIAL OPPORTUNITY OF ABOUT $178 MILLION OVER FIRST 10 YEARS
Reuters
Orchid Pharma Signs Licensing Agreement With Pharmasyntez To Commercialize Exblifep In Russia
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NSE:ORCHPHARMA
- Language
- English (India)
Orchid Pharma Ltd NSE:ORCHPHARMA: